29 November 2005
immatics launches Phase I clinical study on cancer vaccine IMA901 / Only 22 months after the first round of funding ... more» (PDF)
22 November 2005
immatics biotechnologies strengthens Supervisory Board with Dr. Klaus Stöckemann ... more» (PDF)
01 August 2005
immatics receives BMBF grant for development of product candidates for cancer immunotherapy of gastric carcinoma ... more» (PDF)
15 April 2005
immatics receives recognition for progress in cancer immunotherapy ... more» (PDF)
26 January 2005
immatics biotechnologies adds to management team ... more» (PDF)
immatics launches Phase I clinical study on cancer vaccine IMA901 / Only 22 months after the first round of funding ... more» (PDF)
22 November 2005
immatics biotechnologies strengthens Supervisory Board with Dr. Klaus Stöckemann ... more» (PDF)
01 August 2005
immatics receives BMBF grant for development of product candidates for cancer immunotherapy of gastric carcinoma ... more» (PDF)
15 April 2005
immatics receives recognition for progress in cancer immunotherapy ... more» (PDF)
26 January 2005
immatics biotechnologies adds to management team ... more» (PDF)
